INS and obesity disorder: Mice with ablated adipocyte-RXRα are resistant to diet and chemical-induced obesity and exhibit impaired lipolysis during fasting (86); RXR agonists have also been demonstrated to sensitize diabetic and obese mice to insulin (87) and decrease hyperglycemia, hypertriglyceridemia, hyperinsulinemia, and both weight gain and food intake in several rodent models (87–89).